{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:18:51Z","timestamp":1791897531360,"version":"4.3.4"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":109,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Dieses Positionspapier beinhaltet die Empfehlungen der \u00d6sterreichischen Diabetes Gesellschaft zum Management von erwachsenen Patient:innen mit Diabetes mellitus w\u00e4hrend station\u00e4rer Aufenthalte und basiert auf aktueller Evidenz zu Blutglukosezielbereichen, Insulintherapie und Therapie mit oralen\/injizierbaren Antidiabetika w\u00e4hrend station\u00e4rer Aufenthalte. Zus\u00e4tzlich werden Spezialsituationen wie intraven\u00f6se Insulintherapie, begleitende Steroidtherapie sowie die Anwendung von Diabetestechnologie im station\u00e4ren Bereich diskutiert.<\/jats:p>","DOI":"10.1007\/s00508-023-02177-5","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T23:03:25Z","timestamp":1682550205000},"page":"242-255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Diabetesmanagement im Krankenhaus (Update 2023)","Hospital diabetes management (Update 2023)"],"prefix":"10.1007","volume":"135","author":[{"given":"Julia K.","family":"Mader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.","family":"Brix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Aberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Vonbank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Resl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Hochfellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Pieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Stechemesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Sourij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"issue":"9677","key":"2177_CR1","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/S0140-6736(09)60553-5","volume":"373","author":"KM Dungan","year":"2009","unstructured":"Dungan\u00a0KM, Braithwaite\u00a0SS, Preiser\u00a0JC. Stress hyperglycaemia. Lancet. 2009;373(9677):1798\u2013807.","journal-title":"Lancet"},{"issue":"2","key":"2177_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0749-0690(18)30059-4","volume":"15","author":"HK Kamel","year":"1999","unstructured":"Kamel\u00a0HK, Rodriguez-Saldana\u00a0J, Flaherty\u00a0JH, Miller\u00a0DK. Diabetes mellitus among ethnic seniors: contrasts with diabetes in whites. Clin Geriatr Med. 1999;15(2):265\u201378.","journal-title":"Clin Geriatr Med"},{"issue":"2","key":"2177_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0749-0690(18)30055-7","volume":"15","author":"JE Morley","year":"1999","unstructured":"Morley\u00a0JE. An overview of diabetes mellitus in older persons. Clin Geriatr Med. 1999;15(2):211\u201324.","journal-title":"Clin Geriatr Med"},{"issue":"12","key":"2177_CR4","doi-asserted-by":"publisher","first-page":"e541","DOI":"10.1097\/CCM.0000000000001353","volume":"43","author":"DL Carpenter","year":"2015","unstructured":"Carpenter\u00a0DL, Gregg\u00a0SR, Xu\u00a0K, Buchman\u00a0TG, Coopersmith\u00a0CM. Prevalence and impact of unknown diabetes in the ICU. Crit Care Med. 2015;43(12):e541\u2013e50.","journal-title":"Crit Care Med"},{"issue":"6","key":"2177_CR5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4158\/EP11042.OR","volume":"17","author":"CM Swanson","year":"2011","unstructured":"Swanson\u00a0CM, Potter\u00a0DJ, Kongable\u00a0GL, Cook\u00a0CB. Update on inpatient glycemic control in hospitals in the United States. Endocr Pract. 2011;17(6):853\u201361.","journal-title":"Endocr Pract"},{"issue":"4","key":"2177_CR6","doi-asserted-by":"publisher","first-page":"810","DOI":"10.2337\/diacare.28.4.810","volume":"28","author":"FA McAlister","year":"2005","unstructured":"McAlister\u00a0FA, Majumdar\u00a0SR, Blitz\u00a0S, Rowe\u00a0BH, Romney\u00a0J, Marrie\u00a0TJ. The relation between hyperglycemia and outcomes in 2,471\u00a0patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005;28(4):810\u20135.","journal-title":"Diabetes Care"},{"issue":"8","key":"2177_CR7","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2337\/dc10-0304","volume":"33","author":"A Frisch","year":"2010","unstructured":"Frisch\u00a0A, Chandra\u00a0P, Smiley\u00a0D, Peng\u00a0L, Rizzo\u00a0M, Gatcliffe\u00a0C, et\u00a0al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care. 2010;33(8):1783\u20138.","journal-title":"Diabetes Care"},{"issue":"12","key":"2177_CR8","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.4065\/78.12.1471","volume":"78","author":"JS Krinsley","year":"2003","unstructured":"Krinsley\u00a0JS. Association between hyperglycemia and increased hospital mortality in a\u00a0heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78(12):1471\u20138.","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"2177_CR9","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1097\/CCM.0b013e3181b083f7","volume":"37","author":"M Falciglia","year":"2009","unstructured":"Falciglia\u00a0M, Freyberg\u00a0RW, Almenoff\u00a0PL, D\u2019Alessio\u00a0DA, Render\u00a0ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37(12):3001\u20139.","journal-title":"Crit Care Med"},{"issue":"11","key":"2177_CR10","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.2337\/dc08-0672","volume":"31","author":"A Bruno","year":"2008","unstructured":"Bruno\u00a0A, Gregori\u00a0D, Caropreso\u00a0A, Lazzarato\u00a0F, Petrinco\u00a0M, Pagano\u00a0E. Normal glucose values are associated with a\u00a0lower risk of mortality in hospitalized patients. Diabetes Care. 2008;31(11):2209\u201310.","journal-title":"Diabetes Care"},{"issue":"6","key":"2177_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S2213-8587(17)30097-9","volume":"5","author":"C Bommer","year":"2017","unstructured":"Bommer\u00a0C, Heesemann\u00a0E, Sagalova\u00a0V, Manne-Goehler\u00a0J, Atun\u00a0R, Barnighausen\u00a0T, et al. The global economic burden of diabetes in adults aged 20\u201379\u00a0years: a\u00a0cost-of-illness study. Lancet Diabetes Endocrinol. 2017;5(6):423\u201330.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2177_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1478-7954-8-29","volume":"8","author":"JP Boyle","year":"2010","unstructured":"Boyle\u00a0JP, Thompson\u00a0TJ, Gregg\u00a0EW, Barker\u00a0LE, Williamson\u00a0DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29.","journal-title":"Popul Health Metr"},{"issue":"11","key":"2177_CR13","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.2337\/diacare.17.11.1320","volume":"17","author":"S Aro","year":"1994","unstructured":"Aro\u00a0S, Kangas\u00a0T, Reunanen\u00a0A, Salinto\u00a0M, Koivisto\u00a0V. Hospital use among diabetic patients and the general population. Diabetes Care. 1994;17(11):1320\u20139.","journal-title":"Diabetes Care"},{"issue":"12","key":"2177_CR14","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.2337\/diacare.23.12.1774","volume":"23","author":"PT Donnan","year":"2000","unstructured":"Donnan\u00a0PT, Leese\u00a0GP, Morris\u00a0AD, Diabetes\u00a0A. Research in Tayside SMMUC. Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: a\u00a0retrospective cohort study of resource use. Diabetes\u00a0Care. 2000;23(12):1774\u20139.","journal-title":"Diabetes Care"},{"issue":"3","key":"2177_CR15","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1210\/jcem.87.3.8341","volume":"87","author":"GE Umpierrez","year":"2002","unstructured":"Umpierrez\u00a0GE, Isaacs\u00a0SD, Bazargan\u00a0N, You\u00a0X, Thaler\u00a0LM, Kitabchi\u00a0AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J\u00a0Clin Endocrinol Metab. 2002;87(3):978\u201382.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2177_CR16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jdiacomp.2018.04.007","volume":"32","author":"RG McCoy","year":"2018","unstructured":"McCoy\u00a0RG, Herrin\u00a0J, Lipska\u00a0KJ, Shah\u00a0ND. Recurrent hospitalizations for severe hypoglycemia and hyperglycemia among U.S. adults with diabetes. J\u00a0Diabetes Complications. 2018;32(7):693\u2013701.","journal-title":"J Diabetes Complications"},{"issue":"10","key":"2177_CR17","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s11606-017-4095-x","volume":"32","author":"RG McCoy","year":"2017","unstructured":"McCoy\u00a0RG, Lipska\u00a0KJ, Herrin\u00a0J, Jeffery\u00a0MM, Krumholz\u00a0HM, Shah\u00a0ND. Hospital readmissions among commercially insured and medicare advantage beneficiaries with diabetes and the impact of severe hypoglycemic and hyperglycemic events. J\u00a0Gen Intern Med. 2017;32(10):1097\u2013105.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"2177_CR18","doi-asserted-by":"publisher","first-page":"e63675","DOI":"10.1371\/journal.pone.0063675","volume":"8","author":"F Lombardo","year":"2013","unstructured":"Lombardo\u00a0F, Maggini\u00a0M, Gruden\u00a0G, Bruno\u00a0G. Temporal trend in hospitalizations for acute diabetic complications: a\u00a0nationwide study, Italy, 2001\u20132010. PLoS ONE. 2013;8(5):e63675.","journal-title":"PLoS ONE"},{"issue":"6","key":"2177_CR19","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00134-015-3757-6","volume":"41","author":"S Finfer","year":"2015","unstructured":"Australian N\u2011SSIft, New Zealand Intensive Care Society Clinical Trials G, Canadian Critical Care Trials G, Finfer\u00a0S, Chittock\u00a0D, Li\u00a0Y, et al. Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a\u00a0subgroup of patients from the NICE-SUGAR study. Intensive Care Med. 2015;41(6):1037\u201347.","journal-title":"Intensive Care Med"},{"issue":"Suppl 1","key":"2177_CR20","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.2337\/dc18-S014","volume":"41","author":"A American Diabetes","year":"2018","unstructured":"American Diabetes\u00a0A. 14. Diabetes care in the hospital: Standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S144\u2013S51.","journal-title":"Diabetes Care"},{"issue":"1","key":"2177_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2337\/dc16-2215","volume":"40","author":"International Hypoglycaemia Study G","year":"2017","unstructured":"International Hypoglycaemia Study G. Glucose concentrations of less than 3.0\u202fmmol\/L (54\u202fmg\/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2017;40(1):155\u20137.","journal-title":"Diabetes Care"},{"issue":"6","key":"2177_CR22","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.2337\/dc09-9029","volume":"32","author":"ES Moghissi","year":"2009","unstructured":"Moghissi\u00a0ES, Korytkowski\u00a0MT, DiNardo\u00a0M, Einhorn\u00a0D, Hellman\u00a0R, Hirsch\u00a0IB, et\u00a0al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119\u201331.","journal-title":"Diabetes Care"},{"issue":"2","key":"2177_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1055\/s-0043-112653","volume":"126","author":"J Kufeldt","year":"2018","unstructured":"Kufeldt\u00a0J, Kovarova\u00a0M, Adolph\u00a0M, Staiger\u00a0H, Bamberg\u00a0M, Haring\u00a0HU, et\u00a0al. Prevalence and distribution of diabetes mellitus in a\u00a0maximum care hospital: urgent need for HbA1c-screening. Exp Clin Endocrinol Diabetes. 2018;126(2):123\u20139.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"2177_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1210\/jc.2011-2098","volume":"97","author":"GE Umpierrez","year":"2012","unstructured":"Umpierrez\u00a0GE, Hellman\u00a0R, Korytkowski\u00a0MT, Kosiborod\u00a0M, Maynard\u00a0GA, Montori\u00a0VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J\u00a0Clin Endocrinol Metab. 2012;97(1):16\u201338.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2177_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4158\/EP09102.RA","volume":"15","author":"ES Moghissi","year":"2009","unstructured":"Moghissi\u00a0ES, Korytkowski\u00a0MT, DiNardo\u00a0M, Einhorn\u00a0D, Hellman\u00a0R, Hirsch\u00a0IB, et\u00a0al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15(4):353\u201369.","journal-title":"Endocr Pract"},{"issue":"2","key":"2177_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/1573399054022794","volume":"1","author":"AB King","year":"2005","unstructured":"King\u00a0AB, Armstrong\u00a0DU. Basal bolus dosing: a\u00a0clinical experience. Curr Diabetes Rev. 2005;1(2):215\u201320.","journal-title":"Curr Diabetes Rev"},{"issue":"2","key":"2177_CR27","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1210\/jc.2008-1441","volume":"94","author":"GE Umpierrez","year":"2009","unstructured":"Umpierrez\u00a0GE, Hor\u00a0T, Smiley\u00a0D, Temponi\u00a0A, Umpierrez\u00a0D, Ceron\u00a0M, et\u00a0al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. J\u00a0Clin Endocrinol Metab. 2009;94(2):564\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2177_CR28","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2337\/diacare.27.2.553","volume":"27","author":"S Clement","year":"2004","unstructured":"Clement\u00a0S, Braithwaite\u00a0SS, Magee\u00a0MF, Ahmann\u00a0A, Smith\u00a0EP, Schafer\u00a0RG, et\u00a0al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2):553\u201391.","journal-title":"Diabetes Care"},{"issue":"9","key":"2177_CR29","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.2337\/dc07-0295","volume":"30","author":"GE Umpierrez","year":"2007","unstructured":"Umpierrez\u00a0GE, Smiley\u00a0D, Zisman\u00a0A, Prieto\u00a0LM, Palacio\u00a0A, Ceron\u00a0M, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30(9):2181\u20136.","journal-title":"Diabetes Care"},{"issue":"8","key":"2177_CR30","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.2337\/dc10-2434","volume":"34","author":"DJ Rubin","year":"2011","unstructured":"Rubin\u00a0DJ, Rybin\u00a0D, Doros\u00a0G, McDonnell\u00a0ME. Weight-based, insulin dose-related hypoglycemia in hospitalized patients with diabetes. Diabetes Care. 2011;34(8):1723\u20138.","journal-title":"Diabetes Care"},{"issue":"9","key":"2177_CR31","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1111\/dom.14458","volume":"23","author":"DA Hochfellner","year":"2021","unstructured":"Hochfellner\u00a0DA, Rainer\u00a0R, Ziko\u00a0H, Aberer\u00a0F, Simic\u00a0A, Lichtenegger\u00a0KM, Beck\u00a0P, Donsa\u00a0K, Pieber\u00a0TR, Fruhwald\u00a0FM, Rosenkranz\u00a0AR, Kamolz\u00a0LP, Baumann\u00a0PM, Mader\u00a0JK, Plank\u00a0J. Efficient and safe glycaemic control with basal-bolus insulin therapy during fasting periods in hospitalized patients with type\u00a02 diabetes using decision support technology: A\u00a0post hoc analysis. Diabetes Obes Metab. 2021; 23(9):2161\u20139. https:\/\/doi.org\/10.1111\/dom.14458.","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"2177_CR32","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/dme.12756","volume":"32","author":"S George","year":"2015","unstructured":"George\u00a0S, Dale\u00a0J, Stanisstreet\u00a0D. A guideline for the use of variable rate intravenous insulin infusion in medical inpatients. Diabet Med. 2015;32(6):706\u201313.","journal-title":"Diabet Med"},{"issue":"3","key":"2177_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1089\/dia.2006.0015","volume":"9","author":"R Juneja","year":"2007","unstructured":"Juneja\u00a0R, Roudebush\u00a0C, Kumar\u00a0N, Macy\u00a0A, Golas\u00a0A, Wall\u00a0D, et\u00a0al. Utilization of a\u00a0computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol Ther. 2007;9(3):232\u201340.","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"2177_CR34","first-page":"986","volume":"40","author":"American Diabetes Association","year":"2017","unstructured":"American Diabetes Association. Erratum. Diabetes Care in the Hospital. Sec. 14. In Standards of medical care in Diabetes-2017. Diabetes Care 2017;40(Suppl. 1);S120\u2013S127. Diabetes Care. 2017;40(7):986.","journal-title":"Diabetes Care"},{"issue":"11","key":"2177_CR35","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.2337\/db06-0855","volume":"55","author":"G Van den Berghe","year":"2006","unstructured":"Van den Berghe\u00a0G, Wilmer\u00a0A, Milants\u00a0I, Wouters\u00a0PJ, Bouckaert\u00a0B, Bruyninckx\u00a0F, et\u00a0al. Intensive insulin therapy in mixed medical\/surgical intensive care units: benefit versus harm. Diabetes. 2006;55(11):3151\u20139.","journal-title":"Diabetes"},{"issue":"5","key":"2177_CR36","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1067\/mtc.2003.181","volume":"125","author":"AP Furnary","year":"2003","unstructured":"Furnary\u00a0AP, Gao\u00a0G, Grunkemeier\u00a0GL, Wu\u00a0Y, Zerr\u00a0KJ, Bookin\u00a0SO, et\u00a0al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J\u00a0Thorac Cardiovasc Surg. 2003;125(5):1007\u201321.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"2177_CR37","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0003-4975(99)00014-4","volume":"67","author":"AP Furnary","year":"1999","unstructured":"Furnary\u00a0AP, Zerr\u00a0KJ, Grunkemeier\u00a0GL, Starr\u00a0A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67(2):352\u201360. discussion 60\u20132.","journal-title":"Ann Thorac Surg"},{"issue":"19","key":"2177_CR38","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1056\/NEJMoa011300","volume":"345","author":"G van den Berghe","year":"2001","unstructured":"van den Berghe\u00a0G, Wouters\u00a0P, Weekers\u00a0F, Verwaest\u00a0C, Bruyninckx\u00a0F, Schetz\u00a0M, et\u00a0al. Intensive insulin therapy in critically ill patients. N\u00a0Engl J Med. 2001;345(19):1359\u201367.","journal-title":"N Engl J Med"},{"issue":"2","key":"2177_CR39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2337\/diacare.27.2.461","volume":"27","author":"PA Goldberg","year":"2004","unstructured":"Goldberg\u00a0PA, Siegel\u00a0MD, Sherwin\u00a0RS, Halickman\u00a0JI, Lee\u00a0M, Bailey\u00a0VA, et\u00a0al. Implementation of a\u00a0safe and effective insulin infusion protocol in a\u00a0medical intensive care unit. Diabetes Care. 2004;27(2):461\u20137.","journal-title":"Diabetes Care"},{"issue":"10","key":"2177_CR40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11892-017-0919-7","volume":"17","author":"CE Mendez","year":"2017","unstructured":"Mendez\u00a0CE, Umpierrez\u00a0GE. Management of type 1 Diabetes in the hospital setting. Curr Diab Rep. 2017;17(10):98.","journal-title":"Curr Diab Rep"},{"issue":"1","key":"2177_CR41","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1097\/MJT.0000000000001078","volume":"27","author":"A Perez","year":"2020","unstructured":"Perez\u00a0A, Ramos\u00a0A, Carreras\u00a0G. Insulin therapy in hospitalized patients. Am J Ther. 2020;27(1):e71\u2013e8.","journal-title":"Am J Ther"},{"issue":"4","key":"2177_CR42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.7326\/0003-4819-146-4-200702200-00002","volume":"146","author":"GY Gandhi","year":"2007","unstructured":"Gandhi\u00a0GY, Nuttall\u00a0GA, Abel\u00a0MD, Mullany\u00a0CJ, Schaff\u00a0HV, O\u2019Brien\u00a0PC, et\u00a0al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a\u00a0randomized trial. Ann Intern Med. 2007;146(4):233\u201343.","journal-title":"Ann Intern Med"},{"issue":"8","key":"2177_CR43","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/EJA.0b013e3283495ba1","volume":"28","author":"I Smith","year":"2011","unstructured":"Smith\u00a0I, Kranke\u00a0P, Murat\u00a0I, Smith\u00a0A, O\u2019Sullivan\u00a0G, Soreide\u00a0E, et\u00a0al. Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2011;28(8):556\u201369.","journal-title":"Eur J Anaesthesiol"},{"issue":"18","key":"2177_CR44","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1056\/NEJMcp060094","volume":"355","author":"SE Inzucchi","year":"2006","unstructured":"Inzucchi\u00a0SE. Clinical practice. Management of hyperglycemia in the hospital setting. N\u00a0Engl J Med. 2006;355(18):1903\u201311.","journal-title":"N Engl J Med"},{"issue":"6","key":"2177_CR45","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1210\/jc.2003-030347","volume":"88","author":"DL Trence","year":"2003","unstructured":"Trence\u00a0DL, Kelly\u00a0JL, Hirsch\u00a0IB. The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change. J\u00a0Clin Endocrinol Metab. 2003;88(6):2430\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2177_CR46","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2337\/dc16-0989","volume":"40","author":"GE Umpierrez","year":"2017","unstructured":"Umpierrez\u00a0GE, Pasquel\u00a0FJ. Management of inpatient hyperglycemia and Diabetes in older adults. Diabetes Care. 2017;40(4):509\u201317.","journal-title":"Diabetes Care"},{"issue":"12","key":"2177_CR47","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s00330-011-2225-0","volume":"21","author":"F Stacul","year":"2011","unstructured":"Stacul\u00a0F, van der Molen\u00a0AJ, Reimer\u00a0P, Webb\u00a0JA, Thomsen\u00a0HS, Morcos\u00a0SK, et\u00a0al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21(12):2527\u201341.","journal-title":"Eur Radiol"},{"key":"2177_CR48","volume-title":"Positionspapier der Deutschen Diabetes Gesellschaft zur Therapie des Diabetes mellitus im Krankenhaus","author":"Deutsche Diabetesgesellschaft","year":"2018","unstructured":"Deutsche Diabetesgesellschaft. Positionspapier der Deutschen Diabetes Gesellschaft zur Therapie des Diabetes mellitus im Krankenhaus. 2018."},{"issue":"6","key":"2177_CR49","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.kint.2016.09.010","volume":"90","author":"V Perkovic","year":"2016","unstructured":"Perkovic\u00a0V, Agarwal\u00a0R, Fioretto\u00a0P, Hemmelgarn\u00a0BR, Levin\u00a0A, Thomas\u00a0MC, et\u00a0al. Management of patients with diabetes and CKD: conclusions from a\u00a0\u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference. Kidney Int. 2016;90(6):1175\u201383.","journal-title":"Kidney Int"},{"issue":"11","key":"2177_CR50","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1111\/dom.12974","volume":"19","author":"JD Lalau","year":"2017","unstructured":"Lalau\u00a0JD, Kajbaf\u00a0F, Protti\u00a0A, Christensen\u00a0MM, De Broe\u00a0ME, Wiernsperger\u00a0N. Metformin-associated lactic acidosis (MALA): Moving towards a\u00a0new paradigm. Diabetes Obes Metab. 2017;19(11):1502\u201312.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"2177_CR51","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/ajcp\/80.4.484","volume":"80","author":"D Luft","year":"1983","unstructured":"Luft\u00a0D, Deichsel\u00a0G, Schmulling\u00a0RM, Stein\u00a0W, Eggstein\u00a0M. Definition of clinically relevant lactic acidosis in patients with internal diseases. Am J Clin Pathol. 1983;80(4):484\u20139.","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"2177_CR52","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/j.1875-9114.2011.01088.x","volume":"32","author":"CM Deusenberry","year":"2012","unstructured":"Deusenberry\u00a0CM, Coley\u00a0KC, Korytkowski\u00a0MT, Donihi\u00a0AC. Hypoglycemia in hospitalized patients treated with sulfonylureas. Pharmacotherapy. 2012;32(7):613\u20137.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"2177_CR53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S2213-8587(16)30402-8","volume":"5","author":"FJ Pasquel","year":"2017","unstructured":"Pasquel\u00a0FJ, Gianchandani\u00a0R, Rubin\u00a0DJ, Dungan\u00a0KM, Anzola\u00a0I, Gomez\u00a0PC, et al. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a\u00a0multicentre, prospective, open-label, non-inferiority randomised trial. Lancet Diabetes Endocrinol. 2017;5(2):125\u201333.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"2177_CR54","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.2337\/dc13-0277","volume":"36","author":"GE Umpierrez","year":"2013","unstructured":"Umpierrez\u00a0GE, Gianchandani\u00a0R, Smiley\u00a0D, Jacobs\u00a0S, Wesorick\u00a0DH, Newton\u00a0C, et\u00a0al. Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a\u00a0pilot, randomized, controlled study. Diabetes Care. 2013;36(11):3430\u20135.","journal-title":"Diabetes Care"},{"key":"2177_CR55","unstructured":"US Food and Drug Association. FDA adds warnings about heart failure risk to labels of type 2 diabetes medicines containing saxagliptin and alogliptin 2016. 2016. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm486096.htm. Zugegriffen: 8. Aug. 2018."},{"issue":"19","key":"2177_CR56","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso\u00a0SP, Bain\u00a0SC, Consoli\u00a0A, Eliaschewitz\u00a0FG, Jodar\u00a0E, Leiter\u00a0LA, et\u00a0al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N\u00a0Engl J Med. 2016;375(19):1834\u201344.","journal-title":"N Engl J Med"},{"issue":"4","key":"2177_CR57","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso\u00a0SP, Daniels\u00a0GH, Brown-Frandsen\u00a0K, Kristensen\u00a0P, Mann\u00a0JF, Nauck\u00a0MA, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N\u00a0Engl J Med. 2016;375(4):311\u201322.","journal-title":"N Engl J Med"},{"issue":"10157","key":"2177_CR58","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","volume":"392","author":"AF Hernandez","year":"2018","unstructured":"Hernandez\u00a0AF, Green\u00a0JB, Janmohamed\u00a0S, D\u2019Agostino\u00a0RB Sr., Granger\u00a0CB, Jones\u00a0NP, et al. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a\u00a0double-blind, randomised placebo-controlled trial. Lancet. 2018;392(10157):1519\u201329.","journal-title":"Lancet"},{"issue":"10193","key":"2177_CR59","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","volume":"394","author":"HC Gerstein","year":"2019","unstructured":"Gerstein\u00a0HC, Colhoun\u00a0HM, Dagenais\u00a0GR, Diaz\u00a0R, Lakshmanan\u00a0M, Pais\u00a0P, et al. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a\u00a0double-blind, randomised placebo-controlled trial. Lancet. 2019;394(10193):121\u201330.","journal-title":"Lancet"},{"issue":"22","key":"2177_CR60","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman\u00a0B, Wanner\u00a0C, Lachin\u00a0JM, Fitchett\u00a0D, Bluhmki\u00a0E, Hantel\u00a0S, et\u00a0al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N\u00a0Engl J Med. 2015;373(22):2117\u201328.","journal-title":"N Engl J Med"},{"issue":"4","key":"2177_CR61","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrendo.2016.15","volume":"12","author":"G Umpierrez","year":"2016","unstructured":"Umpierrez\u00a0G, Korytkowski\u00a0M. Diabetic emergencies\u2014Ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12(4):222\u201332.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2177_CR62","first-page":"62","volume":"72","author":"DH van Raalte","year":"2014","unstructured":"van Raalte\u00a0DH, Diamant\u00a0M. Steroid diabetes: from mechanism to treatment? Neth J Med. 2014;72(2):62\u201372.","journal-title":"Neth J Med"},{"issue":"8","key":"2177_CR63","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.4239\/wjd.v6.i8.1073","volume":"6","author":"HE Tamez-Perez","year":"2015","unstructured":"Tamez-Perez\u00a0HE, Quintanilla-Flores\u00a0DL, Rodriguez-Gutierrez\u00a0R, Gonzalez-Gonzalez\u00a0JG, Tamez-Pena\u00a0AL. Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative review. World J Diabetes. 2015;6(8):1073\u201381.","journal-title":"World J Diabetes"},{"issue":"2","key":"2177_CR64","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.diabres.2015.02.010","volume":"108","author":"T Katsuyama","year":"2015","unstructured":"Katsuyama\u00a0T, Sada\u00a0KE, Namba\u00a0S, Watanabe\u00a0H, Katsuyama\u00a0E, Yamanari\u00a0T, et al. Risk factors for the development of glucocorticoid-induced diabetes mellitus. Diabetes Res Clin Pract. 2015;108(2):273\u20139.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"2177_CR65","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.bbmt.2017.03.010","volume":"23","author":"MN Stauber","year":"2017","unstructured":"Stauber\u00a0MN, Aberer\u00a0F, Oulhaj\u00a0A, Mader\u00a0JK, Zebisch\u00a0A, Pieber\u00a0TR, et al. Early hyperglycemia after initiation of glucocorticoid therapy predicts adverse outcome in patients with acute graft-versus-host disease. Biol Blood Marrow Transplant. 2017; 23(7):1186\u201392. https:\/\/doi.org\/10.1016\/j.bbmt.2017.03.010.","journal-title":"Biol Blood Marrow Transplant."},{"issue":"3","key":"2177_CR66","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/sj.ki.5000116","volume":"69","author":"J Hjelmesaeth","year":"2006","unstructured":"Hjelmesaeth\u00a0J, Hartmann\u00a0A, Leivestad\u00a0T, Holdaas\u00a0H, Sagedal\u00a0S, Olstad\u00a0M, et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int. 2006;69(3):588\u201395.","journal-title":"Kidney Int"},{"issue":"5","key":"2177_CR67","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4158\/EP08331.RAR","volume":"15","author":"JN Clore","year":"2009","unstructured":"Clore\u00a0JN, Thurby-Hay\u00a0L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009;15(5):469\u201374.","journal-title":"Endocr Pract"},{"issue":"11","key":"2177_CR68","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1210\/js.2018-00262","volume":"2","author":"AL Peters","year":"2018","unstructured":"Peters\u00a0AL, Ahmann\u00a0AJ, Hirsch\u00a0IB, Raymond\u00a0JK. Advances in glucose monitoring and automated insulin delivery: supplement to Endocrine Society clinical practice guidelines. J\u00a0Endocr Soc. 2018;2(11):1214\u201325.","journal-title":"J Endocr Soc"},{"issue":"Suppl 1","key":"2177_CR69","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.2337\/dc22-S007","volume":"45","author":"American Diabetes Association","year":"2022","unstructured":"American Diabetes Association, et al. 7. Diabetes technology: Standards of medical care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S97\u2013S112.","journal-title":"Diabetes Care"},{"issue":"4","key":"2177_CR70","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1177\/1932296818769933","volume":"12","author":"B Thompson","year":"2018","unstructured":"Thompson\u00a0B, Korytkowski\u00a0M, Klonoff\u00a0DC, Cook\u00a0CB. Consensus statement on use of continuous subcutaneous insulin infusion therapy in the hospital. J\u00a0Diabetes Sci Technol. 2018;12(4):880\u20139.","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"2177_CR71","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1177\/193229681200600502","volume":"6","author":"CB Cook","year":"2012","unstructured":"Cook\u00a0CB, Beer\u00a0KA, Seifert\u00a0KM, Boyle\u00a0ME, Mackey\u00a0PA, Castro\u00a0JC. Transitioning insulin pump therapy from the outpatient to the inpatient setting: a\u00a0review of 6\u00a0years\u2019 experience with 253\u00a0cases. J\u00a0Diabetes Sci Technol. 2012;6(5):995\u20131002.","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"2177_CR72","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4158\/EP.13.2.117","volume":"13","author":"CB Cook","year":"2007","unstructured":"Cook\u00a0CB, McNaughton\u00a0DA, Braddy\u00a0CM, Jameson\u00a0KA, Roust\u00a0LR, Smith\u00a0SA, et\u00a0al. Management of inpatient hyperglycemia: assessing perceptions and barriers to care among resident physicians. Endocr Pract. 2007;13(2):117\u201324.","journal-title":"Endocr Pract"},{"issue":"5","key":"2177_CR73","doi-asserted-by":"publisher","first-page":"415","DOI":"10.4158\/EP09063.ORR","volume":"15","author":"ML Noschese","year":"2009","unstructured":"Noschese\u00a0ML, DiNardo\u00a0MM, Donihi\u00a0AC, Gibson\u00a0JM, Koerbel\u00a0GL, Saul\u00a0M, et\u00a0al. Patient outcomes after implementation of a\u00a0protocol for inpatient insulin pump therapy. Endocr Pract. 2009;15(5):415\u201324.","journal-title":"Endocr Pract"},{"issue":"2","key":"2177_CR74","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jcjd.2014.01.011","volume":"38","author":"RL Houlden","year":"2014","unstructured":"Houlden\u00a0RL, Moore\u00a0S. In-hospital management of adults using insulin pump therapy. Can J Diabetes. 2014;38(2):126\u201333.","journal-title":"Can J Diabetes"},{"issue":"3","key":"2177_CR75","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1177\/1932296814522809","volume":"8","author":"S Kannan","year":"2014","unstructured":"Kannan\u00a0S, Satra\u00a0A, Calogeras\u00a0E, Lock\u00a0P, Lansang\u00a0MC. Insulin pump patient characteristics and glucose control in the hospitalized setting. J\u00a0Diabetes Sci Technol. 2014;8(3):473\u20138.","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"2177_CR76","doi-asserted-by":"publisher","first-page":"746","DOI":"10.4158\/EP.16.5.746","volume":"16","author":"G Grunberger","year":"2010","unstructured":"Grunberger\u00a0G, Bailey\u00a0TS, Cohen\u00a0AJ, Flood\u00a0TM, Handelsman\u00a0Y, Hellman\u00a0R, et\u00a0al. Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump management. Endocr Pract. 2010;16(5):746\u201362.","journal-title":"Endocr Pract"},{"issue":"10","key":"2177_CR77","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11892-018-1056-7","volume":"18","author":"B Thompson","year":"2018","unstructured":"Thompson\u00a0B, Leighton\u00a0M, Korytkowski\u00a0M, Cook\u00a0CB. An overview of safety issues on use of insulin pumps and continuous glucose monitoring systems in the hospital. Curr Diab Rep. 2018;18(10):81.","journal-title":"Curr Diab Rep"},{"issue":"2","key":"2177_CR78","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11892-021-01375-7","volume":"21","author":"T Yeh","year":"2021","unstructured":"Yeh\u00a0T, Yeung\u00a0M, Mendelsohn Curanaj\u00a0FA. Managing patients with insulin pumps and continuous glucose monitors in the hospital: to wear or not to wear. Curr Diab Rep. 2021;21(2):7.","journal-title":"Curr Diab Rep"},{"issue":"8","key":"2177_CR79","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2337\/dci18-0002","volume":"41","author":"GE Umpierrez","year":"2018","unstructured":"Umpierrez\u00a0GE, Klonoff\u00a0DC. Diabetes technology update: use of insulin pumps and continuous glucose monitoring in the hospital. Diabetes Care. 2018;41(8):1579\u201389.","journal-title":"Diabetes Care"},{"issue":"10","key":"2177_CR80","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1210\/jc.2010-2756","volume":"96","author":"DC Klonoff","year":"2011","unstructured":"Klonoff\u00a0DC, Buckingham\u00a0B, Christiansen\u00a0JS, Montori\u00a0VM, Tamborlane\u00a0WV, Vigersky\u00a0RA, et\u00a0al. Continuous glucose monitoring: an Endocrine Society clinical practice guideline. J\u00a0Clin Endocrinol Metab. 2011;96(10):2968\u201379.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2177_CR81","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/jhm.2109","volume":"8","author":"MC Lansang","year":"2013","unstructured":"Lansang\u00a0MC, Modic\u00a0MB, Sauvey\u00a0R, Lock\u00a0P, Ross\u00a0D, Combs\u00a0P, et\u00a0al. Approach to the adult hospitalized patient on an insulin pump. J\u00a0Hosp Med. 2013;8(12):721\u20137.","journal-title":"J Hosp Med"},{"issue":"6","key":"2177_CR82","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1089\/dia.2020.0490","volume":"23","author":"SE Tellez","year":"2021","unstructured":"Tellez\u00a0SE, Hornung\u00a0LN, Courter\u00a0JD, Abu-El-Haija\u00a0M, Nathan\u00a0JD, Lawson\u00a0SA, et al. Inaccurate glucose sensor values after hydroxyurea administration. Diabetes Technol Ther. 2021;23(6):443\u201351.","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"2177_CR83","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.2337\/dc20-0670","volume":"43","author":"BG Nair","year":"2020","unstructured":"Nair\u00a0BG, Dellinger\u00a0EP, Flum\u00a0DR, Rooke\u00a0GA, Hirsch\u00a0IB. A pilot study of the feasibility and accuracy of inpatient continuous glucose monitoring. Diabetes Care. 2020;43(11):e168\u2013e9.","journal-title":"Diabetes Care"},{"issue":"9","key":"2177_CR84","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/dia.2014.0343","volume":"17","author":"L Schaupp","year":"2015","unstructured":"Schaupp\u00a0L, Donsa\u00a0K, Neubauer\u00a0KM, Mader\u00a0JK, Aberer\u00a0F, Holl\u00a0B, et al. Taking a\u00a0closer look\u2014Continuous glucose monitoring in non-critically ill hospitalized patients with type 2 diabetes mellitus under basal-bolus insulin therapy. Diabetes Technol Ther. 2015;17(9):611\u20138.","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"2177_CR85","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.2337\/dc19-2073","volume":"43","author":"RJ Galindo","year":"2020","unstructured":"Galindo\u00a0RJ, Migdal\u00a0AL, Davis\u00a0GM, Urrutia\u00a0MA, Albury\u00a0B, Zambrano\u00a0C, et al. Comparison of the freestyle libre pro flash Continuous Glucose Monitoring (CGM) system and point-of-care capillary glucose testing in hospitalized patients with type 2 diabetes treated with basal-bolus insulin regimen. Diabetes Care. 2020;43(11):2730\u20135.","journal-title":"Diabetes Care"},{"issue":"11","key":"2177_CR86","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.2337\/dc20-1016","volume":"43","author":"AL Fortmann","year":"2020","unstructured":"Fortmann\u00a0AL, Spierling Bagsic\u00a0SR, Talavera\u00a0L, Garcia\u00a0IM, Sandoval\u00a0H, Hottinger\u00a0A, et al. Glucose as the fifth vital sign: A randomized controlled trial of continuous glucose monitoring in a\u00a0non-ICU hospital setting. Diabetes Care. 2020;43(11):2873\u20137.","journal-title":"Diabetes Care"},{"issue":"4","key":"2177_CR87","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1177\/1932296821994586","volume":"16","author":"C Dillmann","year":"2022","unstructured":"Dillmann\u00a0C, Amoura\u00a0L, Fall Mostaine\u00a0F, Coste\u00a0A, Bounyar\u00a0L, Kessler\u00a0L. Feasibility of real-time continuous glucose monitoring telemetry system in an inpatient diabetes unit: a pilot study. J\u00a0Diabetes Sci Technol. 2022;16(4):955\u201361.","journal-title":"J Diabetes Sci Technol"},{"issue":"11","key":"2177_CR88","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.2337\/dc20-0840","volume":"43","author":"LG Singh","year":"2020","unstructured":"Singh\u00a0LG, Satyarengga\u00a0M, Marcano\u00a0I, Scott\u00a0WH, Pinault\u00a0LF, Feng\u00a0Z, et al. Reducing inpatient hypoglycemia in the general wards using real-time continuous glucose monitoring: the glucose telemetry system, a\u00a0randomized clinical trial. Diabetes Care. 2020;43(11):2736\u201343.","journal-title":"Diabetes Care"},{"issue":"6","key":"2177_CR89","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1177\/1932296820954163","volume":"14","author":"RJ Galindo","year":"2020","unstructured":"Galindo\u00a0RJ, Umpierrez\u00a0GE, Rushakoff\u00a0RJ, Basu\u00a0A, Lohnes\u00a0S, Nichols\u00a0JH, et\u00a0al. Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline. J\u00a0Diabetes Sci Technol. 2020;14(6):1035\u201364.","journal-title":"J Diabetes Sci Technol"},{"key":"2177_CR90","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1805233","author":"L Bally","year":"2018","unstructured":"Bally\u00a0L, Thabit\u00a0H, Hartnell\u00a0S, Andereggen\u00a0E, Ruan\u00a0Y, Wilinska\u00a0ME, et al. Closed-loop insulin delivery for glycemic control in noncritical care. N\u00a0Engl J Med. 2018; https:\/\/doi.org\/10.1056\/nejmoa1805233.","journal-title":"N Engl J Med"},{"issue":"2","key":"2177_CR91","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S2213-8587(16)30280-7","volume":"5","author":"H Thabit","year":"2017","unstructured":"Thabit\u00a0H, Hartnell\u00a0S, Allen\u00a0JM, Lake\u00a0A, Wilinska\u00a0ME, Ruan\u00a0Y, et al. Closed-loop insulin delivery in inpatients with type 2 diabetes: a\u00a0randomised, parallel-group trial. Lancet Diabetes Endocrinol. 2017;5(2):117\u201324.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2177_CR92","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/193229681300700217","volume":"7","author":"KM Neubauer","year":"2013","unstructured":"Neubauer\u00a0KM, Schaupp\u00a0L, Plank\u00a0J, Augustin\u00a0T, Mautner\u00a0SI, Tschapeller\u00a0B, et\u00a0al. Failure to control hyperglycemia in noncritically ill diabetes patients despite standard glycemic management in a\u00a0hospital setting. J\u00a0Diabetes Sci Technol. 2013;7(2):402\u20139.","journal-title":"J Diabetes Sci Technol"},{"issue":"9","key":"2177_CR93","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1111\/dom.14458","volume":"23","author":"DA Hochfellner","year":"2021","unstructured":"Hochfellner\u00a0DA, Rainer\u00a0R, Ziko\u00a0H, Aberer\u00a0F, Simic\u00a0A, Lichtenegger\u00a0KM, et al. Efficient and safe glycaemic control with basal-bolus insulin therapy during fasting periods in hospitalized patients with type 2 diabetes using decision support technology: A post hoc analysis. Diabetes Obes Metab. 2021;23(9):2161\u20139.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2177_CR94","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1932296816676501","volume":"11","author":"S Spat","year":"2017","unstructured":"Spat\u00a0S, Donsa\u00a0K, Beck\u00a0P, H\u00f6ll\u00a0B, Mader\u00a0JK, Schaupp\u00a0L, et\u00a0al. A mobile computerized decision support system to prevent hypoglycemia in hospitalized patients with type 2 diabetes mellitus. J\u00a0Diabetes Sci Technol. 2017;11(1):20\u20138.","journal-title":"J Diabetes Sci Technol"},{"issue":"10","key":"2177_CR95","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1089\/dia.2015.0027","volume":"17","author":"KM Neubauer","year":"2015","unstructured":"Neubauer\u00a0KM, Mader\u00a0JK, H\u00f6ll\u00a0B, Aberer\u00a0F, Donsa\u00a0K, Augustin\u00a0T, et\u00a0al. Standardized glycemic management with a\u00a0computerized Workflow and decision support system for hospitalized patients with type 2 diabetes on different wards. Diabetes Technol Ther. 2015;17(10):685\u201392.","journal-title":"Diabetes Technol Ther"},{"key":"2177_CR96","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijmedinf.2016.03.007","volume":"90","author":"K Donsa","year":"2016","unstructured":"Donsa\u00a0K, Beck\u00a0P, Holl\u00a0B, Mader\u00a0JK, Schaupp\u00a0L, Plank\u00a0J, et al. Impact of errors in paper-based and computerized diabetes management with decision support for hospitalized patients with type 2 diabetes. A post-hoc analysis of a\u00a0before and after study. Int J Med Inform. 2016;90:58\u201367.","journal-title":"Int J Med Inform"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02177-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-023-02177-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02177-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T23:10:01Z","timestamp":1682550601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-023-02177-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":96,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["2177"],"URL":"https:\/\/doi.org\/10.1007\/s00508-023-02177-5","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"22 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.K.\u00a0Mader: Vortragshonorare von AstraZeneca, Abbott Diabetes Care, B\u00f6hringer-Ingelheim, Eli Lilly, Medtronic Minimed, Menarini, Merck Sharp & Dohme, Nintamed, Novo Nordisk, Roche Diabetes Care, Sanofi-Aventis, Servier, Viatris, Wellion und Ypsomed. Advisory Board: Abbott Diabetes Care, B\u00f6hringer-Ingelheim, Eli Lilly, Medtronic Minimed, Novo Nordisk, Pharmasense, Roche Diabetes Care, Sanofi-Aventis. Gesellschafterin decide Clinical Software GmbH. Forschungsgelder von A.\u00a0Menarini Diagnostics, B. Braun, Metronom Health, Novo Nordisk, Profusa Inc., Roche Diabetes Care, Sanofi-Aventis. J.\u00a0Brix: Honorare von AstraZeneca, Bayer, Boehringer-Ingelheim, Eli Lilly, MSD, Novartis, Novo Nordisk. J.M.\u00a0Brix: Vortragshonorare oder Advisory Boards: Abbott, Boehringer-Ingelheim, Eli Lilly, MSD, NovoNordisk, sanofi-aventis. F.\u00a0Aberer: Vortragshonorare von AMGEN, Astra Zeneca, NovoNordisk, Boehringer Ingelheim, Eli Lilly, Sanofi Aventis und Forschungsgelder von Sanofi Aventis. A.\u00a0Vonbank: Vortrags- und Beratungshonorare Boehringer-Ingelheim, Astra Zeneca, Sanofi-Aventis, Amgen, Novo Nordisk, Eli Lilly, Roche, Daichii Sankyo. M.\u00a0Resl: Vortragshonorare von Novo Nordisk, Viatris, Dexcom, Boehringer-Ingelheim. D.A.\u00a0Hochfellner: Reisehonorare von Eli Lilly, Novo Nordisk, Novartis und MSD. C.\u00a0Ress: Vortragshonorare und Kongressunterst\u00fctzung von AstraZeneca, Novo Nordisk, Pfizer, Boehringer Ingelheim, Amryt und Sanofi. T.R.\u00a0Pieber: Direktor des Institutes f\u00fcr Biomedizin und Gesundheitswissenschaften (HEALTH) von JOANNEUM RESEARCH. Wissenschaftlicher Vorstand von CBmed (Zentrum f\u00fcr Biomarkerforschung). Vortragshonorare von der Firma Novo Nordisk. Mitglied von Advisory Boards von den Firmen Arecor, Novo Nordisk, Sanofi, AstraZeneca, Adocia. L.\u00a0Stechemesser: Forschungsunterst\u00fctzungen und\/oder Honorare von Abbott, AstraZeneca, Boehringer-Ingelheim, Eli Lilly, Medtronic, MSD, Novartis, Novo Nordisk, Roche, Sanofi-Aventis. H.\u00a0Sourij Vortragshonorare oder Advisory Boards: Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, Kapsch, Merck Sharp & Dohme, Novartis, Novo Nordisk, Roche Diagnostics, Sanofi-Aventis. Forschungsuntersgrants: Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Novo Nordisk, Sanofi-Aventis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}